CLINICAL_TRIALS trial_result · 2016-05-05

Clinical Trial Update: ET-blockade and Exercise-induced Vascular Adaptations in T2DM [Phase 4]

A Phase 4 clinical trial investigating endothelin receptor blockade with exercise-induced vascular adaptations in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Radboud University Medical Center | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED